Stay updated on GB002 Open-Label Extension in PAH Clinical Trial
Sign up to get notified when there's something new on the GB002 Open-Label Extension in PAH Clinical Trial page.

Latest updates to the GB002 Open-Label Extension in PAH Clinical Trial page
- Check5 days agoChange DetectedThe page now displays revision v3.7.0, replacing the previous v3.6.6, indicating an update to the page template or system version rather than changes to the study data.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe revision tag on the page updated from v3.6.5 to v3.6.6, indicating a minor maintenance update to the page.SummaryDifference0.0%

- Check26 days agoChange DetectedNo changes detected on the page. The content appears unchanged.SummaryDifference0.1%

- Check41 days agoChange DetectedRevision tag updated from v3.6.4 to v3.6.5 on the page, signaling a new revision of the page metadata. This change does not alter the study information or layout.SummaryDifference0.0%

- Check55 days agoChange DetectedSponsor information updated to Gossamer Bio USA, Inc., replacing GB002, Inc. and related subsidiary wording. The revision now shows v3.6.4 with dates in July 2026.SummaryDifference0.4%

- Check62 days agoChange DetectedThe sponsor/affiliations section was updated to reflect GB002, Inc.'s parent company as Gossamer Bio USA, Inc., replacing references to Gossamer Bio Inc. This change represents a corporate name update for the sponsor organization in the study record.SummaryDifference0.1%

Stay in the know with updates to GB002 Open-Label Extension in PAH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GB002 Open-Label Extension in PAH Clinical Trial page.